ArticleSAGE open medicine2014

Long-term post-marketing surveillance of mizoribine for the treatment of lupus nephritis: Safety and efficacy during a 3-year follow-up.

Nobuyuki Yagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.